HK1177732A1 - 阿戈美拉汀溴化氫水合物及其製備方法 - Google Patents
阿戈美拉汀溴化氫水合物及其製備方法Info
- Publication number
- HK1177732A1 HK1177732A1 HK13104895.3A HK13104895A HK1177732A1 HK 1177732 A1 HK1177732 A1 HK 1177732A1 HK 13104895 A HK13104895 A HK 13104895A HK 1177732 A1 HK1177732 A1 HK 1177732A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- hydrobromide hydrate
- agomelatine hydrobromide
- agomelatine
- hydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101262639A CN102190595A (zh) | 2010-03-17 | 2010-03-17 | 阿戈美拉汀溴化氢水合物及其制备方法 |
PCT/CN2011/071912 WO2011113363A1 (en) | 2010-03-17 | 2011-03-17 | Agomelatine hydrobromide hydrate and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1177732A1 true HK1177732A1 (zh) | 2013-08-30 |
Family
ID=44599557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13104895.3A HK1177732A1 (zh) | 2010-03-17 | 2013-04-23 | 阿戈美拉汀溴化氫水合物及其製備方法 |
Country Status (39)
Country | Link |
---|---|
US (1) | US8729132B2 (zh) |
EP (1) | EP2547650B1 (zh) |
JP (1) | JP5634533B2 (zh) |
KR (1) | KR101406736B1 (zh) |
CN (2) | CN102190595A (zh) |
AP (1) | AP3199A (zh) |
AU (1) | AU2011229619B2 (zh) |
BR (1) | BR112012023173B1 (zh) |
CA (1) | CA2792430C (zh) |
CL (1) | CL2012002541A1 (zh) |
CR (1) | CR20120461A (zh) |
CU (1) | CU20120136A7 (zh) |
CY (1) | CY1117134T1 (zh) |
DK (1) | DK2547650T3 (zh) |
EA (1) | EA022066B1 (zh) |
EC (1) | ECSP12012156A (zh) |
ES (1) | ES2572427T3 (zh) |
GE (1) | GEP20156232B (zh) |
GT (1) | GT201200260A (zh) |
HK (1) | HK1177732A1 (zh) |
HN (1) | HN2012001923A (zh) |
HR (1) | HRP20151343T1 (zh) |
HU (1) | HUE026673T2 (zh) |
IL (1) | IL221783A (zh) |
MA (1) | MA34054B1 (zh) |
ME (1) | ME02309B (zh) |
MX (1) | MX2012010594A (zh) |
MY (1) | MY160337A (zh) |
NI (1) | NI201200141A (zh) |
NZ (1) | NZ602451A (zh) |
PE (1) | PE20130014A1 (zh) |
PL (1) | PL2547650T3 (zh) |
PT (1) | PT2547650E (zh) |
RS (1) | RS54449B1 (zh) |
SG (1) | SG183869A1 (zh) |
SI (1) | SI2547650T1 (zh) |
TN (1) | TN2012000436A1 (zh) |
UA (1) | UA105424C2 (zh) |
WO (1) | WO2011113363A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
WO2013170738A1 (zh) * | 2012-05-14 | 2013-11-21 | 上海右手医药科技开发有限公司 | 阿戈美拉汀酸根复合物及其制备方法和用途 |
CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
PL366150A1 (en) * | 2000-10-30 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
FR2890562B1 (fr) * | 2005-09-09 | 2012-10-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
CN101585779B (zh) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | 阿戈美拉汀的晶型vi及其制备方法和应用 |
-
2010
- 2010-03-17 CN CN2010101262639A patent/CN102190595A/zh active Pending
-
2011
- 2011-03-17 RS RS20150831A patent/RS54449B1/en unknown
- 2011-03-17 CA CA2792430A patent/CA2792430C/en active Active
- 2011-03-17 SG SG2012065017A patent/SG183869A1/en unknown
- 2011-03-17 GE GEAP201112870A patent/GEP20156232B/en unknown
- 2011-03-17 DK DK11755680.3T patent/DK2547650T3/en active
- 2011-03-17 WO PCT/CN2011/071912 patent/WO2011113363A1/en active Application Filing
- 2011-03-17 KR KR1020127026897A patent/KR101406736B1/ko active IP Right Grant
- 2011-03-17 EP EP11755680.3A patent/EP2547650B1/en active Active
- 2011-03-17 MX MX2012010594A patent/MX2012010594A/es active IP Right Grant
- 2011-03-17 NZ NZ602451A patent/NZ602451A/en not_active IP Right Cessation
- 2011-03-17 JP JP2012557393A patent/JP5634533B2/ja active Active
- 2011-03-17 UA UAA201211719A patent/UA105424C2/uk unknown
- 2011-03-17 AP AP2012006493A patent/AP3199A/xx active
- 2011-03-17 AU AU2011229619A patent/AU2011229619B2/en not_active Ceased
- 2011-03-17 EA EA201201293A patent/EA022066B1/ru unknown
- 2011-03-17 BR BR112012023173-1A patent/BR112012023173B1/pt not_active IP Right Cessation
- 2011-03-17 MA MA35191A patent/MA34054B1/fr unknown
- 2011-03-17 US US13/635,087 patent/US8729132B2/en active Active
- 2011-03-17 MY MYPI2012700614A patent/MY160337A/en unknown
- 2011-03-17 ME MEP-2016-9A patent/ME02309B/me unknown
- 2011-03-17 SI SI201130723T patent/SI2547650T1/sl unknown
- 2011-03-17 PT PT117556803T patent/PT2547650E/pt unknown
- 2011-03-17 PL PL11755680T patent/PL2547650T3/pl unknown
- 2011-03-17 CN CN201180024413.8A patent/CN102892749B/zh not_active Expired - Fee Related
- 2011-03-17 PE PE2012001449A patent/PE20130014A1/es active IP Right Grant
- 2011-03-17 HU HUE11755680A patent/HUE026673T2/en unknown
- 2011-03-17 ES ES11755680T patent/ES2572427T3/es active Active
-
2012
- 2012-08-31 TN TNP2012000436A patent/TN2012000436A1/en unknown
- 2012-09-04 IL IL221783A patent/IL221783A/en not_active IP Right Cessation
- 2012-09-11 CR CR20120461A patent/CR20120461A/es unknown
- 2012-09-12 NI NI201200141A patent/NI201200141A/es unknown
- 2012-09-13 CL CL2012002541A patent/CL2012002541A1/es unknown
- 2012-09-14 HN HN2012001923A patent/HN2012001923A/es unknown
- 2012-09-14 EC ECSP12012156 patent/ECSP12012156A/es unknown
- 2012-09-17 CU CU2012000136A patent/CU20120136A7/es unknown
- 2012-09-17 GT GT201200260A patent/GT201200260A/es unknown
-
2013
- 2013-04-23 HK HK13104895.3A patent/HK1177732A1/zh not_active IP Right Cessation
-
2015
- 2015-12-08 HR HRP20151343TT patent/HRP20151343T1/hr unknown
-
2016
- 2016-01-18 CY CY20161100041T patent/CY1117134T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
HK1187049A1 (zh) | 雙芳基連接的芳基三唑酮及其用途 | |
HRP20150071T1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
GB201012175D0 (en) | Procedure and mechanisms | |
ZA201208173B (en) | Peptices and their use | |
EP2657188A4 (en) | FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME | |
EP2548859A4 (en) | PREPARATION OF METHYL-D3-AMINE AND SALTS THEREOF | |
IL232362A0 (en) | The chemical composition containing fluorine and its use | |
HRP20182083T1 (hr) | Nova kombinacija i uporaba | |
PT2521445T (pt) | Formulação e utilização da mesma | |
EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF | |
HK1177732A1 (zh) | 阿戈美拉汀溴化氫水合物及其製備方法 | |
EP2615094A4 (en) | SESTERTERPEN COMPOUNDS AND THEIR USE | |
GB201006479D0 (en) | Garment and use thereof | |
EP2638160A4 (en) | NUCLIONS AND RIBOCAPSIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230321 |